Terms: = Gastric cancer AND EZH2, ENX-1, 2146, ENSG00000106462, Q15910, MGC9169
159 results:
1. Pharmacology and pharmacokinetics of tazemetostat.
Orleni M; Beumer JH
Cancer Chemother Pharmacol; 2024 May; 93(5):509-517. PubMed ID: 38520556
[TBL] [Abstract] [Full Text] [Related]
2. The Role of Epstein-Barr Virus (EBV) Infected gastric cancer in Increasing microRNA124 (miR-124) Promoter Methylation and Enhancer of Zeste Homolog 2 (ezh2) Gene Expression.
Ghoreshi ZA; Rezaei Zadeh Rukerd M; Askarpour H; Kheirkhah Vakilabad AA; Nakhaie M; Abbaszadeh Afshar MJ; Behboudi E; Charostad J; Arefinia N
Medicine (Baltimore); 2024 Mar; 103(12):e36534. PubMed ID: 38517989
[TBL] [Abstract] [Full Text] [Related]
3. E-cadherin loss drives diffuse-type gastric tumorigenesis via ezh2-mediated reprogramming.
Zou G; Huang Y; Zhang S; Ko KP; Kim B; Zhang J; Venkatesan V; Pizzi MP; Fan Y; Jun S; Niu N; Wang H; Song S; Ajani JA; Park JI
J Exp Med; 2024 Apr; 221(4):. PubMed ID: 38411616
[TBL] [Abstract] [Full Text] [Related]
4. ezh2-interacting lncRNAs contribute to gastric tumorigenesis; a review on the mechanisms of action.
Mohebbi H; Esbati R; Hamid RA; Akhavanfar R; Radi UK; Siri G; Yazdani O
Mol Biol Rep; 2024 Feb; 51(1):334. PubMed ID: 38393645
[TBL] [Abstract] [Full Text] [Related]
5. ezh2 as a potential therapeutic target for gastrointestinal cancers.
Hashemi M; Nazdari N; Gholamiyan G; Paskeh MDA; Jafari AM; Nemati F; Khodaei E; Abyari G; Behdadfar N; Raei B; Raesi R; Nabavi N; Hu P; Rashidi M; Taheriazam A; Entezari M
Pathol Res Pract; 2024 Jan; 253():154988. PubMed ID: 38118215
[TBL] [Abstract] [Full Text] [Related]
6. The Role of CDK20 Protein in Carcinogenesis.
Chivukula S; Malkhed V
Curr Drug Targets; 2023; 24(10):790-796. PubMed ID: 37469151
[TBL] [Abstract] [Full Text] [Related]
7. Exploring the Potential Mechanism of Action of Ursolic Acid against gastric cancer and COVID-19 using Network Pharmacology and Bioinformatics Analysis.
Liu Z; Huang H; Yu Y; Jia Y; Li L; Shi X; Wang F
Curr Pharm Des; 2023; 29(16):1274-1292. PubMed ID: 37218202
[TBL] [Abstract] [Full Text] [Related]
8. ezh2 regulates pancreatic cancer cells through E2F1, GLI1, CDK3, and Mcm4.
Li H; Wang H; Cui Y; Jiang W; Zhan H; Feng L; Gao M; Zhao K; Zhang L; Xie X; Zhao N; Li Y; Liu P
Hereditas; 2023 May; 160(1):23. PubMed ID: 37198697
[TBL] [Abstract] [Full Text] [Related]
9. Identification and validation of a novel prognostic circadian rhythm-related gene signature for stomach adenocarcinoma.
Qian L; Ding X; Fan X; Li S; Qiao Y; Zhang X; Li J
Chronobiol Int; 2023 Jun; 40(6):744-758. PubMed ID: 37122167
[TBL] [Abstract] [Full Text] [Related]
10. B-cell-specific Moloney murine leukemia virus integration site 1 knockdown impairs adriamycin resistance of gastric cancer cells.
Ma N; Zhao S; Yang W; Wang Y
Arab J Gastroenterol; 2023 Aug; 24(3):168-174. PubMed ID: 36878814
[TBL] [Abstract] [Full Text] [Related]
11. Dual-Regulated Mechanism of ezh2 and KDM6A on SALL4 Modulates Tumor Progression via Wnt/β-Catenin Pathway in gastric cancer.
Ren L; Deng H; Jiang Y; Liu C
Dig Dis Sci; 2023 Apr; 68(4):1292-1305. PubMed ID: 36877334
[TBL] [Abstract] [Full Text] [Related]
12. Identification and Treatment of SMARCA4 Deficient Poorly Differentiated gastric Carcinoma.
Bhat V; Koneru M; Knapp K; Joneja U; Morrison J; Hong YK
Am Surg; 2023 Nov; 89(11):4987-4989. PubMed ID: 36533880
[TBL] [Abstract] [Full Text] [Related]
13. Tumor- and metastasis-promoting roles of miR-488 inhibition via HULC enhancement and ezh2-mediated p53 repression in gastric cancer.
Yang D; Shi M; You Q; Zhang Y; Hu Z; Xu J; Cai Q; Zhu Z
Cell Biol Toxicol; 2023 Aug; 39(4):1341-1358. PubMed ID: 36449143
[TBL] [Abstract] [Full Text] [Related]
14. Multiplexed immunofluorescence analysis of CAF-markers, ezh2 and FOXM1 in gastric tissue: associations with clinicopathological parameters and clinical outcomes.
Sun H; Wang X; Zhang X; Wang X; Tan C; Weng W; Zhang M; Ni S; Wang L; Huang D; Xu M; Sheng W
BMC Cancer; 2022 Nov; 22(1):1188. PubMed ID: 36401232
[TBL] [Abstract] [Full Text] [Related]
15. SMYD3 regulates gastric cancer progression and macrophage polarization through ezh2 methylation.
Wang P; Zhao L; Rui Y; Ding Y
Cancer Gene Ther; 2023 Apr; 30(4):575-581. PubMed ID: 36127410
[TBL] [Abstract] [Full Text] [Related]
16. TGF-β1/Smad3 upregulates UCA1 to promote liver fibrosis through DKK1 and miR18a.
Yang Z; Zhang H; Yin M; Cheng Z; Jiang P; Feng M; Liu Z; Liao B
J Mol Med (Berl); 2022 Oct; 100(10):1465-1478. PubMed ID: 36001113
[TBL] [Abstract] [Full Text] [Related]
17. OCT4-mediated transcription confers oncogenic advantage for a subset of gastric tumors with poor clinical outcome.
Pandian J; Panneerpandian P; Sekar BT; Selvarasu K; Ganesan K
Funct Integr Genomics; 2022 Dec; 22(6):1345-1360. PubMed ID: 35987846
[TBL] [Abstract] [Full Text] [Related]
18. Poorly Cohesive gastric cancers Showing the Transcriptomic Hallmarks of Epithelial-Mesenchymal Transition Behave Aggressively.
Bencivenga M; Simbolo M; Ciaparrone C; Vicentini C; Torroni L; Piredda ML; Sacco M; Alloggio M; Castelli C; Tomezzoli A; Scarpa A; De Manzoni G
Ann Surg; 2022 Nov; 276(5):822-829. PubMed ID: 35930005
[TBL] [Abstract] [Full Text] [Related]
19. BMP2 inhibits cell proliferation by downregulating ezh2 in gastric cancer.
Chen Z; Yuan L; Li X; Yu J; Xu Z
Cell Cycle; 2022 Nov; 21(21):2298-2308. PubMed ID: 35856444
[TBL] [Abstract] [Full Text] [Related]
20. Long non-coding RNA ZNF674-AS1 antagonizes oxaliplatin resistance of gastric cancer via regulating ezh2-mediated methylation of CHST7.
Ye K; Wang Y
Aging (Albany NY); 2022 Jul; 14(13):5523-5536. PubMed ID: 35802620
[TBL] [Abstract] [Full Text] [Related]
[Next]
